Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
about
Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental ReproducibilityUse of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza virusesCombination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza VirusesNeuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar FluidPandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model.Antiviral drug resistance as an adaptive processEpistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza virusesResistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.Ultrasensitive Fluorogenic Reagents for Neuraminidase Titration.Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses
P2860
Q24288661-6904FA91-5DCA-4383-86E2-E5FD6AF702DDQ26859435-EF56ADA8-FB96-4BBD-A56B-45B612DD8595Q30364319-18C19084-DF53-463A-81AC-0A9866411829Q30384081-047D47EE-E51C-4FC7-B175-945D03385EBFQ30384874-84D2EEC0-24B7-4092-90F6-42779E93A9B9Q30424185-649347CF-7803-45A6-AFFA-AA708A2C1F84Q33878407-646ADF44-445B-44C1-A443-7E7CB0DF21F9Q34339407-61293835-335A-48A9-AEA9-F6A7AAF938ACQ37074496-A2215180-9DF9-44E2-9513-737C7715750EQ37547236-A67F9CCB-3667-4CD4-BE79-C20B1EDB29D7Q37713074-63F50229-2698-4A20-B6FA-FD575DC5651DQ40138039-673A0717-EBBD-4D29-901C-C5A2292BBF6BQ40335210-29DE4C8A-7934-4A85-8E67-9C9CD43E28E7Q58455370-5C448527-F8B1-4B9B-966F-932480859A66
P2860
Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Comparable fitness and transmi ...... H275Y neuraminidase mutation.
@ast
Comparable fitness and transmi ...... H275Y neuraminidase mutation.
@en
type
label
Comparable fitness and transmi ...... H275Y neuraminidase mutation.
@ast
Comparable fitness and transmi ...... H275Y neuraminidase mutation.
@en
prefLabel
Comparable fitness and transmi ...... H275Y neuraminidase mutation.
@ast
Comparable fitness and transmi ...... H275Y neuraminidase mutation.
@en
P2093
P2860
P50
P356
P1433
P1476
Comparable fitness and transmi ...... e H275Y neuraminidase mutation
@en
P2093
Diana D Y Wong
Hsin-Ping Chiu
Ka-Tim Choy
Michael C W Chan
Renee W Y Chan
Sin Fun Sia
P2860
P304
10558-10570
P356
10.1128/JVI.00985-12
P577
2012-07-18T00:00:00Z